Not long now Mathew , as painful as it is ,
Management working diligently probably waiting for the news before they can announce , importantly the doctors are happy with C-Pulse , implants ??? ,a little over 2 weeks for NUB 1 and expedited pathway to approval for CP2 could drop anytime from now , no doubt deals are being discussed and will come together after the news , better chance of getting a better deal , Finance ? EU trial offering recovery will attract a CEO , paying partner ? up front payment ? . were not dead yet , no competition , technology too good and the only one offering recovery as an end point.
SHC Price at posting:
2.5¢ Sentiment: Buy Disclosure: Held